Important regulator of cell cycle progression. Involved in G1 arrest. Potent inhibitor of cyclin E- and cyclin A-CDK2 complexes. Forms a complex with cyclin type D-CDK4 complexes and is involved in the assembly, stability, and modulation of CCND1- CDK4 complex activation. Acts either as an inhibitor or an activator of cyclin type D-CDK4 complexes depending on its phosphorylation state and/or stoichometry (By similarity).
Chiang, Huang, Wu, Huang, Yeh, Chen, Hsu, Chen, Kuo, Chueh, Juang, Hung, Yeh, Pang: "Interferon α-inducible protein 27 is an oncogene and highly expressed in cholangiocarcinoma patients with poor survival." in: Cancer management and research, Vol. 11, pp. 1893-1905, (2019) (PubMed).
Hsieh, Huang, Wang, Ming, Tsai, Pang: "IFI27, a novel epidermal growth factor-stabilized protein, is functionally involved in proliferation and cell cycling of human epidermal keratinocytes." in: Cell proliferation, (2015) (PubMed).
Stadler, Rexhepaj, Singan, Murphy, Pepperkok, Uhlén, Simpson, Lundberg: "Immunofluorescence and fluorescent-protein tagging show high correlation for protein localization in mammalian cells." in: Nature methods, Vol. 10, Issue 4, pp. 315-23, (2013) (PubMed).
Nzeusseu Toukap, Galant, Theate, Maudoux, Lories, Houssiau, Lauwerys: "Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus." in: Arthritis and rheumatism, Vol. 56, Issue 5, pp. 1579-88, (2007) (PubMed).
Suomela, Cao, Bowcock, Saarialho-Kere: "Interferon alpha-inducible protein 27 (IFI27) is upregulated in psoriatic skin and certain epithelial cancers." in: The Journal of investigative dermatology, Vol. 122, Issue 3, pp. 717-21, (2004) (PubMed).